nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—sarcoma—liver cancer	0.717	1	CtDrD
Thiotepa—CYP2B6—Sorafenib—liver cancer	0.0696	0.476	CbGbCtD
Thiotepa—CYP2B6—Doxorubicin—liver cancer	0.0422	0.289	CbGbCtD
Thiotepa—CYP3A4—Sorafenib—liver cancer	0.0214	0.146	CbGbCtD
Thiotepa—CYP3A4—Doxorubicin—liver cancer	0.013	0.0887	CbGbCtD
Thiotepa—CYP2B6—Liver X Receptor Pathway—SCD—liver cancer	0.00111	0.0861	CbGpPWpGaD
Thiotepa—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.000837	0.0651	CbGpPWpGaD
Thiotepa—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.000503	0.0391	CbGpPWpGaD
Thiotepa—CYP2B6—CYP2E1 reactions—CYP2E1—liver cancer	0.000471	0.0366	CbGpPWpGaD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000362	0.0281	CbGpPWpGaD
Thiotepa—Erythema—Sorafenib—liver cancer	0.00036	0.00291	CcSEcCtD
Thiotepa—Malnutrition—Sorafenib—liver cancer	0.00036	0.00291	CcSEcCtD
Thiotepa—Neoplasm malignant—Epirubicin—liver cancer	0.000357	0.00288	CcSEcCtD
Thiotepa—Delirium—Epirubicin—liver cancer	0.000354	0.00286	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00035	0.0273	CbGpPWpGaD
Thiotepa—Extravasation—Epirubicin—liver cancer	0.000349	0.00282	CcSEcCtD
Thiotepa—Amenorrhoea—Epirubicin—liver cancer	0.000347	0.0028	CcSEcCtD
Thiotepa—Injection site pain—Doxorubicin—liver cancer	0.000345	0.00279	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000344	0.0268	CbGpPWpGaD
Thiotepa—Skin discolouration—Epirubicin—liver cancer	0.000337	0.00273	CcSEcCtD
Thiotepa—Hyperbilirubinaemia—Epirubicin—liver cancer	0.000335	0.00271	CcSEcCtD
Thiotepa—Anaemia—Sorafenib—liver cancer	0.000333	0.00269	CcSEcCtD
Thiotepa—Oliguria—Epirubicin—liver cancer	0.000331	0.00267	CcSEcCtD
Thiotepa—Neoplasm malignant—Doxorubicin—liver cancer	0.00033	0.00267	CcSEcCtD
Thiotepa—Hyperuricaemia—Epirubicin—liver cancer	0.000329	0.00265	CcSEcCtD
Thiotepa—Delirium—Doxorubicin—liver cancer	0.000328	0.00265	CcSEcCtD
Thiotepa—Extravasation—Doxorubicin—liver cancer	0.000323	0.00261	CcSEcCtD
Thiotepa—Leukopenia—Sorafenib—liver cancer	0.000323	0.00261	CcSEcCtD
Thiotepa—CYP2B6—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000322	0.0251	CbGpPWpGaD
Thiotepa—Blood bilirubin increased—Epirubicin—liver cancer	0.000322	0.0026	CcSEcCtD
Thiotepa—Amenorrhoea—Doxorubicin—liver cancer	0.000321	0.00259	CcSEcCtD
Thiotepa—Cough—Sorafenib—liver cancer	0.000315	0.00254	CcSEcCtD
Thiotepa—Skin discolouration—Doxorubicin—liver cancer	0.000312	0.00252	CcSEcCtD
Thiotepa—Hypertension—Sorafenib—liver cancer	0.000311	0.00251	CcSEcCtD
Thiotepa—Blood uric acid increased—Epirubicin—liver cancer	0.00031	0.00251	CcSEcCtD
Thiotepa—Hyperbilirubinaemia—Doxorubicin—liver cancer	0.00031	0.00251	CcSEcCtD
Thiotepa—Arthralgia—Sorafenib—liver cancer	0.000307	0.00248	CcSEcCtD
Thiotepa—Myalgia—Sorafenib—liver cancer	0.000307	0.00248	CcSEcCtD
Thiotepa—Oliguria—Doxorubicin—liver cancer	0.000306	0.00247	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000305	0.00246	CcSEcCtD
Thiotepa—Hyperuricaemia—Doxorubicin—liver cancer	0.000304	0.00246	CcSEcCtD
Thiotepa—Dermatitis contact—Epirubicin—liver cancer	0.000301	0.00243	CcSEcCtD
Thiotepa—Blood bilirubin increased—Doxorubicin—liver cancer	0.000298	0.00241	CcSEcCtD
Thiotepa—Cystitis noninfective—Epirubicin—liver cancer	0.000298	0.00241	CcSEcCtD
Thiotepa—Cystitis—Epirubicin—liver cancer	0.000294	0.00238	CcSEcCtD
Thiotepa—Colitis—Epirubicin—liver cancer	0.000293	0.00236	CcSEcCtD
Thiotepa—Infection—Sorafenib—liver cancer	0.000292	0.00236	CcSEcCtD
Thiotepa—CYP2B6—Xenobiotics—CYP2E1—liver cancer	0.000292	0.0227	CbGpPWpGaD
Thiotepa—Skin exfoliation—Epirubicin—liver cancer	0.000291	0.00235	CcSEcCtD
Thiotepa—Fluid retention—Epirubicin—liver cancer	0.000289	0.00234	CcSEcCtD
Thiotepa—Nervous system disorder—Sorafenib—liver cancer	0.000289	0.00233	CcSEcCtD
Thiotepa—Thrombocytopenia—Sorafenib—liver cancer	0.000288	0.00233	CcSEcCtD
Thiotepa—Blood urea increased—Epirubicin—liver cancer	0.000288	0.00232	CcSEcCtD
Thiotepa—Blood uric acid increased—Doxorubicin—liver cancer	0.000287	0.00232	CcSEcCtD
Thiotepa—Skin disorder—Sorafenib—liver cancer	0.000286	0.00231	CcSEcCtD
Thiotepa—Anorexia—Sorafenib—liver cancer	0.00028	0.00227	CcSEcCtD
Thiotepa—Dermatitis contact—Doxorubicin—liver cancer	0.000279	0.00225	CcSEcCtD
Thiotepa—Oesophagitis—Epirubicin—liver cancer	0.000278	0.00225	CcSEcCtD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.000277	0.0216	CbGpPWpGaD
Thiotepa—Bladder pain—Epirubicin—liver cancer	0.000276	0.00223	CcSEcCtD
Thiotepa—Cystitis noninfective—Doxorubicin—liver cancer	0.000275	0.00223	CcSEcCtD
Thiotepa—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.000273	0.0212	CbGpPWpGaD
Thiotepa—Cystitis—Doxorubicin—liver cancer	0.000272	0.0022	CcSEcCtD
Thiotepa—Pulmonary oedema—Epirubicin—liver cancer	0.000271	0.00219	CcSEcCtD
Thiotepa—Colitis—Doxorubicin—liver cancer	0.000271	0.00219	CcSEcCtD
Thiotepa—Skin exfoliation—Doxorubicin—liver cancer	0.000269	0.00218	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000268	0.00217	CcSEcCtD
Thiotepa—Fluid retention—Doxorubicin—liver cancer	0.000268	0.00216	CcSEcCtD
Thiotepa—Blood urea increased—Doxorubicin—liver cancer	0.000266	0.00215	CcSEcCtD
Thiotepa—Sepsis—Epirubicin—liver cancer	0.000264	0.00214	CcSEcCtD
Thiotepa—Dyspepsia—Sorafenib—liver cancer	0.000259	0.00209	CcSEcCtD
Thiotepa—Oesophagitis—Doxorubicin—liver cancer	0.000258	0.00208	CcSEcCtD
Thiotepa—Decreased appetite—Sorafenib—liver cancer	0.000256	0.00207	CcSEcCtD
Thiotepa—Bladder pain—Doxorubicin—liver cancer	0.000255	0.00206	CcSEcCtD
Thiotepa—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.000254	0.00206	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Sorafenib—liver cancer	0.000254	0.00205	CcSEcCtD
Thiotepa—Fatigue—Sorafenib—liver cancer	0.000254	0.00205	CcSEcCtD
Thiotepa—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.000254	0.0197	CbGpPWpGaD
Thiotepa—Constipation—Sorafenib—liver cancer	0.000252	0.00203	CcSEcCtD
Thiotepa—Pain—Sorafenib—liver cancer	0.000252	0.00203	CcSEcCtD
Thiotepa—Pulmonary oedema—Doxorubicin—liver cancer	0.000251	0.00203	CcSEcCtD
Thiotepa—Hepatic failure—Epirubicin—liver cancer	0.000246	0.00199	CcSEcCtD
Thiotepa—Sepsis—Doxorubicin—liver cancer	0.000245	0.00198	CcSEcCtD
Thiotepa—Gastrointestinal pain—Sorafenib—liver cancer	0.000241	0.00194	CcSEcCtD
Thiotepa—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.000235	0.0019	CcSEcCtD
Thiotepa—Urticaria—Sorafenib—liver cancer	0.000234	0.00189	CcSEcCtD
Thiotepa—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.000233	0.0181	CbGpPWpGaD
Thiotepa—Abdominal pain—Sorafenib—liver cancer	0.000233	0.00188	CcSEcCtD
Thiotepa—Body temperature increased—Sorafenib—liver cancer	0.000233	0.00188	CcSEcCtD
Thiotepa—Hepatic failure—Doxorubicin—liver cancer	0.000228	0.00184	CcSEcCtD
Thiotepa—Cardiac failure—Epirubicin—liver cancer	0.000227	0.00183	CcSEcCtD
Thiotepa—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.000224	0.0174	CbGpPWpGaD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000222	0.0173	CbGpPWpGaD
Thiotepa—Hypersensitivity—Sorafenib—liver cancer	0.000217	0.00175	CcSEcCtD
Thiotepa—Asthenia—Sorafenib—liver cancer	0.000211	0.00171	CcSEcCtD
Thiotepa—Cardiac arrest—Epirubicin—liver cancer	0.00021	0.0017	CcSEcCtD
Thiotepa—Cardiac failure—Doxorubicin—liver cancer	0.00021	0.00169	CcSEcCtD
Thiotepa—CYP2B6—Xenobiotics—CYP1A1—liver cancer	0.00021	0.0163	CbGpPWpGaD
Thiotepa—Pruritus—Sorafenib—liver cancer	0.000208	0.00168	CcSEcCtD
Thiotepa—Ataxia—Epirubicin—liver cancer	0.000208	0.00168	CcSEcCtD
Thiotepa—Blood creatinine increased—Epirubicin—liver cancer	0.000207	0.00167	CcSEcCtD
Thiotepa—Dehydration—Epirubicin—liver cancer	0.000206	0.00166	CcSEcCtD
Thiotepa—Diarrhoea—Sorafenib—liver cancer	0.000201	0.00163	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.000199	0.00161	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000195	0.00158	CcSEcCtD
Thiotepa—Cardiac arrest—Doxorubicin—liver cancer	0.000195	0.00157	CcSEcCtD
Thiotepa—Dizziness—Sorafenib—liver cancer	0.000195	0.00157	CcSEcCtD
Thiotepa—Ataxia—Doxorubicin—liver cancer	0.000192	0.00156	CcSEcCtD
Thiotepa—Blood creatinine increased—Doxorubicin—liver cancer	0.000192	0.00155	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000191	0.0149	CbGpPWpGaD
Thiotepa—Dehydration—Doxorubicin—liver cancer	0.00019	0.00154	CcSEcCtD
Thiotepa—Vomiting—Sorafenib—liver cancer	0.000187	0.00151	CcSEcCtD
Thiotepa—Rash—Sorafenib—liver cancer	0.000186	0.0015	CcSEcCtD
Thiotepa—Dermatitis—Sorafenib—liver cancer	0.000185	0.0015	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000184	0.00149	CcSEcCtD
Thiotepa—Headache—Sorafenib—liver cancer	0.000184	0.00149	CcSEcCtD
Thiotepa—Pancytopenia—Epirubicin—liver cancer	0.000182	0.00147	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000181	0.00146	CcSEcCtD
Thiotepa—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.00018	0.014	CbGpPWpGaD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00018	0.014	CbGpPWpGaD
Thiotepa—Dysuria—Epirubicin—liver cancer	0.000179	0.00144	CcSEcCtD
Thiotepa—Nausea—Sorafenib—liver cancer	0.000175	0.00141	CcSEcCtD
Thiotepa—Weight increased—Epirubicin—liver cancer	0.000174	0.00141	CcSEcCtD
Thiotepa—Hyperglycaemia—Epirubicin—liver cancer	0.000172	0.00139	CcSEcCtD
Thiotepa—Pneumonia—Epirubicin—liver cancer	0.000171	0.00139	CcSEcCtD
Thiotepa—Infestation—Epirubicin—liver cancer	0.00017	0.00138	CcSEcCtD
Thiotepa—Infestation NOS—Epirubicin—liver cancer	0.00017	0.00138	CcSEcCtD
Thiotepa—Pancytopenia—Doxorubicin—liver cancer	0.000168	0.00136	CcSEcCtD
Thiotepa—Renal failure—Epirubicin—liver cancer	0.000168	0.00135	CcSEcCtD
Thiotepa—Jaundice—Epirubicin—liver cancer	0.000166	0.00134	CcSEcCtD
Thiotepa—Stomatitis—Epirubicin—liver cancer	0.000166	0.00134	CcSEcCtD
Thiotepa—Conjunctivitis—Epirubicin—liver cancer	0.000166	0.00134	CcSEcCtD
Thiotepa—Dysuria—Doxorubicin—liver cancer	0.000165	0.00134	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.000164	0.0128	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—UGDH—liver cancer	0.000164	0.0128	CbGpPWpGaD
Thiotepa—Haematuria—Epirubicin—liver cancer	0.000163	0.00131	CcSEcCtD
Thiotepa—Hepatobiliary disease—Epirubicin—liver cancer	0.000161	0.0013	CcSEcCtD
Thiotepa—Weight increased—Doxorubicin—liver cancer	0.000161	0.0013	CcSEcCtD
Thiotepa—Epistaxis—Epirubicin—liver cancer	0.000161	0.0013	CcSEcCtD
Thiotepa—Hyperglycaemia—Doxorubicin—liver cancer	0.00016	0.00129	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.000159	0.0124	CbGpPWpGaD
Thiotepa—Agranulocytosis—Epirubicin—liver cancer	0.000159	0.00129	CcSEcCtD
Thiotepa—Pneumonia—Doxorubicin—liver cancer	0.000159	0.00128	CcSEcCtD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.000159	0.0123	CbGpPWpGaD
Thiotepa—Infestation—Doxorubicin—liver cancer	0.000158	0.00127	CcSEcCtD
Thiotepa—Infestation NOS—Doxorubicin—liver cancer	0.000158	0.00127	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.000157	0.0122	CbGpPWpGaD
Thiotepa—Renal failure—Doxorubicin—liver cancer	0.000155	0.00125	CcSEcCtD
Thiotepa—Haemoglobin—Epirubicin—liver cancer	0.000154	0.00124	CcSEcCtD
Thiotepa—Stomatitis—Doxorubicin—liver cancer	0.000154	0.00124	CcSEcCtD
Thiotepa—Jaundice—Doxorubicin—liver cancer	0.000154	0.00124	CcSEcCtD
Thiotepa—Conjunctivitis—Doxorubicin—liver cancer	0.000153	0.00124	CcSEcCtD
Thiotepa—Haemorrhage—Epirubicin—liver cancer	0.000153	0.00124	CcSEcCtD
Thiotepa—Urinary tract disorder—Epirubicin—liver cancer	0.000151	0.00122	CcSEcCtD
Thiotepa—Haematuria—Doxorubicin—liver cancer	0.00015	0.00122	CcSEcCtD
Thiotepa—Connective tissue disorder—Epirubicin—liver cancer	0.00015	0.00122	CcSEcCtD
Thiotepa—Urethral disorder—Epirubicin—liver cancer	0.00015	0.00121	CcSEcCtD
Thiotepa—Hepatobiliary disease—Doxorubicin—liver cancer	0.000149	0.00121	CcSEcCtD
Thiotepa—Epistaxis—Doxorubicin—liver cancer	0.000149	0.0012	CcSEcCtD
Thiotepa—Agranulocytosis—Doxorubicin—liver cancer	0.000147	0.00119	CcSEcCtD
Thiotepa—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.000146	0.0114	CbGpPWpGaD
Thiotepa—Eye disorder—Epirubicin—liver cancer	0.000143	0.00116	CcSEcCtD
Thiotepa—Tinnitus—Epirubicin—liver cancer	0.000143	0.00115	CcSEcCtD
Thiotepa—Haemoglobin—Doxorubicin—liver cancer	0.000142	0.00115	CcSEcCtD
Thiotepa—Cardiac disorder—Epirubicin—liver cancer	0.000142	0.00115	CcSEcCtD
Thiotepa—Haemorrhage—Doxorubicin—liver cancer	0.000142	0.00114	CcSEcCtD
Thiotepa—Urinary tract disorder—Doxorubicin—liver cancer	0.00014	0.00113	CcSEcCtD
Thiotepa—Connective tissue disorder—Doxorubicin—liver cancer	0.000139	0.00112	CcSEcCtD
Thiotepa—Angiopathy—Epirubicin—liver cancer	0.000139	0.00112	CcSEcCtD
Thiotepa—Urethral disorder—Doxorubicin—liver cancer	0.000139	0.00112	CcSEcCtD
Thiotepa—Immune system disorder—Epirubicin—liver cancer	0.000138	0.00112	CcSEcCtD
Thiotepa—Mediastinal disorder—Epirubicin—liver cancer	0.000138	0.00111	CcSEcCtD
Thiotepa—Chills—Epirubicin—liver cancer	0.000137	0.00111	CcSEcCtD
Thiotepa—Arrhythmia—Epirubicin—liver cancer	0.000137	0.0011	CcSEcCtD
Thiotepa—Alopecia—Epirubicin—liver cancer	0.000135	0.00109	CcSEcCtD
Thiotepa—Mental disorder—Epirubicin—liver cancer	0.000134	0.00108	CcSEcCtD
Thiotepa—Malnutrition—Epirubicin—liver cancer	0.000133	0.00108	CcSEcCtD
Thiotepa—Erythema—Epirubicin—liver cancer	0.000133	0.00108	CcSEcCtD
Thiotepa—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.000133	0.0103	CbGpPWpGaD
Thiotepa—Eye disorder—Doxorubicin—liver cancer	0.000132	0.00107	CcSEcCtD
Thiotepa—Tinnitus—Doxorubicin—liver cancer	0.000132	0.00107	CcSEcCtD
Thiotepa—Cardiac disorder—Doxorubicin—liver cancer	0.000131	0.00106	CcSEcCtD
Thiotepa—Tension—Epirubicin—liver cancer	0.000131	0.00106	CcSEcCtD
Thiotepa—Nervousness—Epirubicin—liver cancer	0.000129	0.00105	CcSEcCtD
Thiotepa—Back pain—Epirubicin—liver cancer	0.000129	0.00104	CcSEcCtD
Thiotepa—Angiopathy—Doxorubicin—liver cancer	0.000128	0.00104	CcSEcCtD
Thiotepa—Immune system disorder—Doxorubicin—liver cancer	0.000128	0.00103	CcSEcCtD
Thiotepa—Mediastinal disorder—Doxorubicin—liver cancer	0.000128	0.00103	CcSEcCtD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000128	0.00993	CbGpPWpGaD
Thiotepa—Chills—Doxorubicin—liver cancer	0.000127	0.00103	CcSEcCtD
Thiotepa—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000127	0.00987	CbGpPWpGaD
Thiotepa—Arrhythmia—Doxorubicin—liver cancer	0.000127	0.00102	CcSEcCtD
Thiotepa—Vision blurred—Epirubicin—liver cancer	0.000126	0.00101	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000125	0.00976	CbGpPWpGaD
Thiotepa—Alopecia—Doxorubicin—liver cancer	0.000125	0.00101	CcSEcCtD
Thiotepa—Mental disorder—Doxorubicin—liver cancer	0.000124	0.001	CcSEcCtD
Thiotepa—Erythema—Doxorubicin—liver cancer	0.000123	0.000996	CcSEcCtD
Thiotepa—Malnutrition—Doxorubicin—liver cancer	0.000123	0.000996	CcSEcCtD
Thiotepa—Anaemia—Epirubicin—liver cancer	0.000123	0.000995	CcSEcCtD
Thiotepa—Agitation—Epirubicin—liver cancer	0.000122	0.000989	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000121	0.00943	CbGpPWpGaD
Thiotepa—Tension—Doxorubicin—liver cancer	0.000121	0.000977	CcSEcCtD
Thiotepa—Nervousness—Doxorubicin—liver cancer	0.00012	0.000967	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00012	0.00931	CbGpPWpGaD
Thiotepa—Leukopenia—Epirubicin—liver cancer	0.000119	0.000964	CcSEcCtD
Thiotepa—Back pain—Doxorubicin—liver cancer	0.000119	0.000963	CcSEcCtD
Thiotepa—Cough—Epirubicin—liver cancer	0.000116	0.000939	CcSEcCtD
Thiotepa—Vision blurred—Doxorubicin—liver cancer	0.000116	0.000939	CcSEcCtD
Thiotepa—Convulsion—Epirubicin—liver cancer	0.000115	0.000933	CcSEcCtD
Thiotepa—Hypertension—Epirubicin—liver cancer	0.000115	0.000929	CcSEcCtD
Thiotepa—Anaemia—Doxorubicin—liver cancer	0.000114	0.000921	CcSEcCtD
Thiotepa—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000114	0.00887	CbGpPWpGaD
Thiotepa—Arthralgia—Epirubicin—liver cancer	0.000113	0.000916	CcSEcCtD
Thiotepa—Myalgia—Epirubicin—liver cancer	0.000113	0.000916	CcSEcCtD
Thiotepa—Agitation—Doxorubicin—liver cancer	0.000113	0.000915	CcSEcCtD
Thiotepa—Anxiety—Epirubicin—liver cancer	0.000113	0.000913	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000113	0.00091	CcSEcCtD
Thiotepa—Leukopenia—Doxorubicin—liver cancer	0.00011	0.000892	CcSEcCtD
Thiotepa—Confusional state—Epirubicin—liver cancer	0.00011	0.000886	CcSEcCtD
Thiotepa—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000109	0.00851	CbGpPWpGaD
Thiotepa—Infection—Epirubicin—liver cancer	0.000108	0.000873	CcSEcCtD
Thiotepa—Cough—Doxorubicin—liver cancer	0.000108	0.000869	CcSEcCtD
Thiotepa—Convulsion—Doxorubicin—liver cancer	0.000107	0.000863	CcSEcCtD
Thiotepa—Nervous system disorder—Epirubicin—liver cancer	0.000107	0.000862	CcSEcCtD
Thiotepa—Thrombocytopenia—Epirubicin—liver cancer	0.000106	0.00086	CcSEcCtD
Thiotepa—Hypertension—Doxorubicin—liver cancer	0.000106	0.00086	CcSEcCtD
Thiotepa—Tachycardia—Epirubicin—liver cancer	0.000106	0.000857	CcSEcCtD
Thiotepa—Skin disorder—Epirubicin—liver cancer	0.000106	0.000853	CcSEcCtD
Thiotepa—Myalgia—Doxorubicin—liver cancer	0.000105	0.000848	CcSEcCtD
Thiotepa—Arthralgia—Doxorubicin—liver cancer	0.000105	0.000848	CcSEcCtD
Thiotepa—Anxiety—Doxorubicin—liver cancer	0.000105	0.000845	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000104	0.000842	CcSEcCtD
Thiotepa—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000104	0.00807	CbGpPWpGaD
Thiotepa—Anorexia—Epirubicin—liver cancer	0.000104	0.000837	CcSEcCtD
Thiotepa—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000104	0.00807	CbGpPWpGaD
Thiotepa—Confusional state—Doxorubicin—liver cancer	0.000101	0.00082	CcSEcCtD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000101	0.00787	CbGpPWpGaD
Thiotepa—Infection—Doxorubicin—liver cancer	0.0001	0.000808	CcSEcCtD
Thiotepa—CYP3A4—Irinotecan Pathway—APC—liver cancer	9.93e-05	0.00773	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Epirubicin—liver cancer	9.91e-05	0.0008	CcSEcCtD
Thiotepa—Nervous system disorder—Doxorubicin—liver cancer	9.87e-05	0.000797	CcSEcCtD
Thiotepa—Thrombocytopenia—Doxorubicin—liver cancer	9.85e-05	0.000796	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	9.82e-05	0.00765	CbGpPWpGaD
Thiotepa—Tachycardia—Doxorubicin—liver cancer	9.82e-05	0.000793	CcSEcCtD
Thiotepa—Skin disorder—Doxorubicin—liver cancer	9.77e-05	0.00079	CcSEcCtD
Thiotepa—Paraesthesia—Epirubicin—liver cancer	9.76e-05	0.000789	CcSEcCtD
Thiotepa—Somnolence—Epirubicin—liver cancer	9.67e-05	0.000781	CcSEcCtD
Thiotepa—Anorexia—Doxorubicin—liver cancer	9.59e-05	0.000775	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—NR1H4—liver cancer	9.58e-05	0.00746	CbGpPWpGaD
Thiotepa—Dyspepsia—Epirubicin—liver cancer	9.57e-05	0.000773	CcSEcCtD
Thiotepa—CYP3A4—Xenobiotics—CYP1A1—liver cancer	9.53e-05	0.00742	CbGpPWpGaD
Thiotepa—Decreased appetite—Epirubicin—liver cancer	9.45e-05	0.000764	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—GSTA3—liver cancer	9.42e-05	0.00733	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Epirubicin—liver cancer	9.39e-05	0.000758	CcSEcCtD
Thiotepa—Fatigue—Epirubicin—liver cancer	9.37e-05	0.000757	CcSEcCtD
Thiotepa—Constipation—Epirubicin—liver cancer	9.3e-05	0.000751	CcSEcCtD
Thiotepa—Pain—Epirubicin—liver cancer	9.3e-05	0.000751	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTA3—liver cancer	9.29e-05	0.00723	CbGpPWpGaD
Thiotepa—Musculoskeletal discomfort—Doxorubicin—liver cancer	9.17e-05	0.000741	CcSEcCtD
Thiotepa—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	9.16e-05	0.00713	CbGpPWpGaD
Thiotepa—Paraesthesia—Doxorubicin—liver cancer	9.03e-05	0.00073	CcSEcCtD
Thiotepa—Feeling abnormal—Epirubicin—liver cancer	8.96e-05	0.000724	CcSEcCtD
Thiotepa—Somnolence—Doxorubicin—liver cancer	8.94e-05	0.000723	CcSEcCtD
Thiotepa—Gastrointestinal pain—Epirubicin—liver cancer	8.89e-05	0.000718	CcSEcCtD
Thiotepa—Dyspepsia—Doxorubicin—liver cancer	8.86e-05	0.000716	CcSEcCtD
Thiotepa—Decreased appetite—Doxorubicin—liver cancer	8.75e-05	0.000707	CcSEcCtD
Thiotepa—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	8.71e-05	0.00678	CbGpPWpGaD
Thiotepa—Gastrointestinal disorder—Doxorubicin—liver cancer	8.69e-05	0.000702	CcSEcCtD
Thiotepa—Fatigue—Doxorubicin—liver cancer	8.67e-05	0.000701	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	8.67e-05	0.00675	CbGpPWpGaD
Thiotepa—Urticaria—Epirubicin—liver cancer	8.64e-05	0.000698	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—GSTA4—liver cancer	8.61e-05	0.0067	CbGpPWpGaD
Thiotepa—Constipation—Doxorubicin—liver cancer	8.6e-05	0.000695	CcSEcCtD
Thiotepa—Pain—Doxorubicin—liver cancer	8.6e-05	0.000695	CcSEcCtD
Thiotepa—Body temperature increased—Epirubicin—liver cancer	8.6e-05	0.000694	CcSEcCtD
Thiotepa—Abdominal pain—Epirubicin—liver cancer	8.6e-05	0.000694	CcSEcCtD
Thiotepa—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—liver cancer	8.59e-05	0.00669	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTA4—liver cancer	8.49e-05	0.00661	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTA2—liver cancer	8.39e-05	0.00653	CbGpPWpGaD
Thiotepa—Feeling abnormal—Doxorubicin—liver cancer	8.29e-05	0.00067	CcSEcCtD
Thiotepa—Gastrointestinal pain—Doxorubicin—liver cancer	8.23e-05	0.000665	CcSEcCtD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	8.19e-05	0.00638	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTA1—liver cancer	8.1e-05	0.0063	CbGpPWpGaD
Thiotepa—Hypersensitivity—Epirubicin—liver cancer	8.01e-05	0.000647	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—NAT2—liver cancer	8.01e-05	0.00623	CbGpPWpGaD
Thiotepa—Urticaria—Doxorubicin—liver cancer	7.99e-05	0.000646	CcSEcCtD
Thiotepa—Body temperature increased—Doxorubicin—liver cancer	7.95e-05	0.000643	CcSEcCtD
Thiotepa—Abdominal pain—Doxorubicin—liver cancer	7.95e-05	0.000643	CcSEcCtD
Thiotepa—CYP2B6—Metapathway biotransformation—NAT2—liver cancer	7.9e-05	0.00615	CbGpPWpGaD
Thiotepa—Asthenia—Epirubicin—liver cancer	7.8e-05	0.00063	CcSEcCtD
Thiotepa—Pruritus—Epirubicin—liver cancer	7.69e-05	0.000622	CcSEcCtD
Thiotepa—CYP3A4—Biological oxidations—UGDH—liver cancer	7.45e-05	0.0058	CbGpPWpGaD
Thiotepa—Diarrhoea—Epirubicin—liver cancer	7.44e-05	0.000601	CcSEcCtD
Thiotepa—Hypersensitivity—Doxorubicin—liver cancer	7.41e-05	0.000599	CcSEcCtD
Thiotepa—Asthenia—Doxorubicin—liver cancer	7.22e-05	0.000583	CcSEcCtD
Thiotepa—Dizziness—Epirubicin—liver cancer	7.19e-05	0.000581	CcSEcCtD
Thiotepa—Pruritus—Doxorubicin—liver cancer	7.12e-05	0.000575	CcSEcCtD
Thiotepa—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	7.06e-05	0.00549	CbGpPWpGaD
Thiotepa—Vomiting—Epirubicin—liver cancer	6.91e-05	0.000559	CcSEcCtD
Thiotepa—Diarrhoea—Doxorubicin—liver cancer	6.88e-05	0.000556	CcSEcCtD
Thiotepa—Rash—Epirubicin—liver cancer	6.86e-05	0.000554	CcSEcCtD
Thiotepa—Dermatitis—Epirubicin—liver cancer	6.85e-05	0.000553	CcSEcCtD
Thiotepa—Headache—Epirubicin—liver cancer	6.81e-05	0.00055	CcSEcCtD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	6.81e-05	0.0053	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GPX3—liver cancer	6.71e-05	0.00523	CbGpPWpGaD
Thiotepa—Dizziness—Doxorubicin—liver cancer	6.65e-05	0.000538	CcSEcCtD
Thiotepa—Nausea—Epirubicin—liver cancer	6.46e-05	0.000522	CcSEcCtD
Thiotepa—CYP2B6—Biological oxidations—HPGDS—liver cancer	6.4e-05	0.00498	CbGpPWpGaD
Thiotepa—Vomiting—Doxorubicin—liver cancer	6.4e-05	0.000517	CcSEcCtD
Thiotepa—Rash—Doxorubicin—liver cancer	6.34e-05	0.000513	CcSEcCtD
Thiotepa—Dermatitis—Doxorubicin—liver cancer	6.34e-05	0.000512	CcSEcCtD
Thiotepa—Headache—Doxorubicin—liver cancer	6.3e-05	0.000509	CcSEcCtD
Thiotepa—Nausea—Doxorubicin—liver cancer	5.98e-05	0.000483	CcSEcCtD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	5.7e-05	0.00444	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	5.51e-05	0.00429	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	5.43e-05	0.00423	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP2E1—liver cancer	5.22e-05	0.00406	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP2E1—liver cancer	5.15e-05	0.00401	CbGpPWpGaD
Thiotepa—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	4.89e-05	0.00381	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GGT1—liver cancer	4.79e-05	0.00373	CbGpPWpGaD
Thiotepa—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	4.71e-05	0.00367	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	4.46e-05	0.00348	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—NR1H4—liver cancer	4.35e-05	0.00339	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTP1—liver cancer	4.3e-05	0.00335	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA3—liver cancer	4.28e-05	0.00333	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTP1—liver cancer	4.24e-05	0.0033	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	4.22e-05	0.00329	CbGpPWpGaD
Thiotepa—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	3.96e-05	0.00308	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—GSTM1—liver cancer	3.95e-05	0.00308	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA4—liver cancer	3.91e-05	0.00305	CbGpPWpGaD
Thiotepa—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	3.9e-05	0.00304	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—GSTM1—liver cancer	3.9e-05	0.00304	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	3.86e-05	0.003	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA2—liver cancer	3.81e-05	0.00297	CbGpPWpGaD
Thiotepa—CYP2B6—Biological oxidations—CYP1A1—liver cancer	3.75e-05	0.00292	CbGpPWpGaD
Thiotepa—CYP2B6—Metapathway biotransformation—CYP1A1—liver cancer	3.7e-05	0.00288	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTA1—liver cancer	3.68e-05	0.00286	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—NAT2—liver cancer	3.64e-05	0.00283	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	3.59e-05	0.00279	CbGpPWpGaD
Thiotepa—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	3.21e-05	0.0025	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	3.05e-05	0.00238	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—HPGDS—liver cancer	2.91e-05	0.00226	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—UGDH—liver cancer	2.8e-05	0.00218	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—EPT1—liver cancer	2.64e-05	0.00205	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—TAT—liver cancer	2.5e-05	0.00195	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP2E1—liver cancer	2.37e-05	0.00185	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	2.34e-05	0.00182	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GGT1—liver cancer	2.18e-05	0.00169	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTP1—liver cancer	1.96e-05	0.00152	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	1.93e-05	0.0015	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—GSTM1—liver cancer	1.8e-05	0.0014	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	1.77e-05	0.00138	CbGpPWpGaD
Thiotepa—CYP3A4—Biological oxidations—CYP1A1—liver cancer	1.7e-05	0.00133	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GLUL—liver cancer	1.7e-05	0.00132	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CPT1B—liver cancer	1.7e-05	0.00132	CbGpPWpGaD
Thiotepa—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	1.68e-05	0.00131	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NR1H4—liver cancer	1.64e-05	0.00128	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA3—liver cancer	1.61e-05	0.00125	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA4—liver cancer	1.47e-05	0.00115	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA2—liver cancer	1.44e-05	0.00112	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTA1—liver cancer	1.38e-05	0.00108	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—NAT2—liver cancer	1.37e-05	0.00107	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALDOB—liver cancer	1.31e-05	0.00102	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—UGDH—liver cancer	1.27e-05	0.000992	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CRABP1—liver cancer	1.25e-05	0.000975	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—EPT1—liver cancer	1.2e-05	0.000933	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—TAT—liver cancer	1.14e-05	0.000884	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HPGDS—liver cancer	1.09e-05	0.000852	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PSMD10—liver cancer	9.76e-06	0.00076	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PSMA4—liver cancer	9.76e-06	0.00076	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GOT2—liver cancer	9.49e-06	0.000739	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP2E1—liver cancer	8.92e-06	0.000695	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYCS—liver cancer	8.35e-06	0.00065	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GGT1—liver cancer	8.19e-06	0.000638	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GOT1—liver cancer	8.19e-06	0.000638	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CPT1B—liver cancer	7.72e-06	0.000601	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GLUL—liver cancer	7.72e-06	0.000601	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NR1H4—liver cancer	7.44e-06	0.000579	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTP1—liver cancer	7.36e-06	0.000573	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA3—liver cancer	7.32e-06	0.00057	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—HMOX1—liver cancer	7.26e-06	0.000565	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—GSTM1—liver cancer	6.76e-06	0.000526	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA4—liver cancer	6.69e-06	0.000521	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA2—liver cancer	6.52e-06	0.000508	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—CYP1A1—liver cancer	6.41e-06	0.000499	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTA1—liver cancer	6.29e-06	0.00049	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—NAT2—liver cancer	6.22e-06	0.000484	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—MTHFR—liver cancer	5.98e-06	0.000465	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALDOB—liver cancer	5.97e-06	0.000464	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARA—liver cancer	5.86e-06	0.000456	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CRABP1—liver cancer	5.69e-06	0.000443	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CG—liver cancer	5.02e-06	0.000391	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HPGDS—liver cancer	4.97e-06	0.000387	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PPARG—liver cancer	4.85e-06	0.000377	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PSMD10—liver cancer	4.43e-06	0.000345	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PSMA4—liver cancer	4.43e-06	0.000345	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CD—liver cancer	4.41e-06	0.000344	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—ALB—liver cancer	4.36e-06	0.000339	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GOT2—liver cancer	4.31e-06	0.000336	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP2E1—liver cancer	4.05e-06	0.000316	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CB—liver cancer	3.85e-06	0.0003	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYCS—liver cancer	3.79e-06	0.000295	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GOT1—liver cancer	3.72e-06	0.00029	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GGT1—liver cancer	3.72e-06	0.00029	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTP1—liver cancer	3.34e-06	0.00026	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—HMOX1—liver cancer	3.3e-06	0.000257	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—GSTM1—liver cancer	3.07e-06	0.000239	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—CYP1A1—liver cancer	2.91e-06	0.000227	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—MTHFR—liver cancer	2.72e-06	0.000211	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARA—liver cancer	2.66e-06	0.000207	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—PIK3CA—liver cancer	2.35e-06	0.000183	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CG—liver cancer	2.28e-06	0.000178	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PPARG—liver cancer	2.2e-06	0.000171	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CD—liver cancer	2.01e-06	0.000156	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—ALB—liver cancer	1.98e-06	0.000154	CbGpPWpGaD
Thiotepa—CYP2B6—Metabolism—AKT1—liver cancer	1.92e-06	0.000149	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CB—liver cancer	1.75e-06	0.000136	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—PIK3CA—liver cancer	1.07e-06	8.3e-05	CbGpPWpGaD
Thiotepa—CYP3A4—Metabolism—AKT1—liver cancer	8.71e-07	6.78e-05	CbGpPWpGaD
